Insights from the 12th International Workshop on Waldenstrom's Macroglobulinemia
- PMID: 40579051
- DOI: 10.1053/j.seminhematol.2025.05.001
Insights from the 12th International Workshop on Waldenstrom's Macroglobulinemia
Conflict of interest statement
Declaration of Competing Interest SPT has received research funding and/or consulting fees from Abbvie/Pharmacyclics, Janssen, Beigene, Lilly, BMS, and Ono Pharmaceuticals. CJP has no conflicts to report. JVM reports receiving consulting fees from Beigene. CB reports consultancy, honoraria, advisory board, and travel expenses from Roche/Genentech, Janssen, BeiGene, Novartis, Pfizer, Incyte, AbbVie, Gilead, Celltrion, MorphoSys, Regeneron, Sobi, and Lilly.
Publication types
LinkOut - more resources
Full Text Sources
